TY - JOUR
AU1 - Stadler, Nicola
AU2 - Fingernagel, Thomas
AU3 - Hofstaetter, Stefan G.
AU4 - Trieb, Klemens
AB - Although the giant cell tumor of bone is generally classified as a benign tumor it can rarely metastasize and has a potential risk of local recurrence. We want to report about a female patient who suffered from a recurrence of a giant cell tumor of bone after the implantation of a total endoprosthesis of the knee joint. We have treated her with denosumab, which is a receptor activator of nuclear factor kappa-B ligand inhibitor. In this case report we want to present a new option to treat this kind of neoplasm.
TI - A Recurrent Giant Cell Tumor of Bone Treated with Denosumab
JF - Clinics and Practice
DO - 10.4081/cp.2015.697
DA - 2015-02-10
UR - https://www.deepdyve.com/lp/multidisciplinary-digital-publishing-institute/a-recurrent-giant-cell-tumor-of-bone-treated-with-denosumab-daoOrpMGjx
SP - 6
EP - 7
VL - 5
IS - 1
DP - DeepDyve
ER -